Muutke küpsiste eelistusi

E-raamat: Continuous Glucose Monitors: A Guide for Primary Care Clinicians [Taylor & Francis e-raamat]

  • Formaat: 100 pages, 22 Tables, black and white; 14 Line drawings, black and white; 8 Halftones, black and white; 22 Illustrations, black and white
  • Ilmumisaeg: 21-Nov-2025
  • Kirjastus: CRC Press
  • ISBN-13: 9781003656180
Teised raamatud teemal:
  • Taylor & Francis e-raamat
  • Hind: 258,50 €*
  • * hind, mis tagab piiramatu üheaegsete kasutajate arvuga ligipääsu piiramatuks ajaks
  • Tavahind: 369,29 €
  • Säästad 30%
Continuous Glucose Monitors: A Guide for Primary Care CliniciansSuurem pilt
  • Formaat: 100 pages, 22 Tables, black and white; 14 Line drawings, black and white; 8 Halftones, black and white; 22 Illustrations, black and white
  • Ilmumisaeg: 21-Nov-2025
  • Kirjastus: CRC Press
  • ISBN-13: 9781003656180
Teised raamatud teemal:
Taylor & Francis e-raamatudRohkem infot Taylor & Francis e-raamatute kohta

This book provides an in-depth exploration of Continuous Glucose Monitoring (CGM), covering accuracy metrics, glycemic data interpretation, clinical applications, and recent advancements. It is an essential guide for researchers, clinicians, and students in diabetes management, biomedical science, and engineering.



This book presents the latest advancements in Continuous Glucose Monitoring (CGM), offering a focused and practical guide for clinicians to effectively prescribe, interpret, and integrate CGM data into patient care.

With an emphasis on recent developments, it delivers essential insights into emerging CGM technologies, accuracy metrics, and clinical applications. Continuous Glucose Monitors: A Guide for Primary Care Clinicians:

  • Covers the most recent Continuous Glucose Monitoring devices, including over-the-counter options, and their clinical implications
  • Examines accuracy metrics such as MARD, PARD, and error grids for improved data interpretation
  • Provides guidance on billing, coding, and insurance considerations to streamline clinical implementation
  • Explores CGM efficacy across different populations, including athletes, elderly patients, and individuals with gestational diabetes
  • Discusses barriers to adoption, disparities in access, and the future of CGM technology.

This book will be beneficial for graduate and postgraduate students, clinicians, researchers, healthcare professionals, and academicians in the fields of endocrinology, diabetes management, biomedical engineering, and clinical practice.

Contents
Preface......................................................................
.................................................ix
Acknowledgments..............................................................
........................................x
Chapter 1 History of
CGMs.........................................................................
.........1
Chapter 2 Technology
.............................................................................
............10
Chapter 3
Accuracy.....................................................................
........................17
Chapter 4 Data Interpretation and Ambulatory Glucose Profile
.........................25
Chapter 5 OTC CGMs
.............................................................................
...........32
Chapter 6 Prescription CGM
Indications............................................................36
Chapter 7
Efficacy.....................................................................
..........................39
Chapter 8 Billing and Coding
.............................................................................
46
Chapter 9 Adverse Effects and Interfering
Substances.......................................52
Chapter 10 Adoption and
Barriers.....................................................................
...56
Chapter 11
Disparities..................................................................
.........................62
Chapter 12 Insurance Coverage
Complexities......................................................64
Chapter 13 Privacy of CGM
Data.........................................................................
66
Chapter 14 AI + CGM
.............................................................................
.............70
Chapter 15 Fitness, Athletes, and
CGMs..............................................................73
Chapter 16 Research on Psychiatric Effects of
CGMs.........................................77
Chapter 17 Controversy
.............................................................................
...........79
Chapter 18 Case Studies
.............................................................................
..........81
Chapter 19 Future
Directions................................................................................85
Laura Solano teaches genetics at A.T. Still University, USA. She graduated from the University of North Texas Health Sciences with a masters in physician assistant studies. She has practiced faithfully in primary care for over a decade. In 2022, she graduated from A.T. Still University with a Doctorate in Medical Sciences and has published several research and education articles.
Püsilink: https://www.kriso.ee/db/9781003656180_pe.html
Märksõnad: